Harnessing the human monocyte system to improve surgical recovery

利用人类单核细胞系统改善手术康复

基本信息

  • 批准号:
    10675540
  • 负责人:
  • 金额:
    $ 40.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Harnessing the human monocyte system to improve surgical recovery Over 30 million patients undergo a major surgery annually in the US. Patients’ recovery after surgery is highly variable and can be severely compromised by complications, such as infections, prolonged pain, and functional impairment. However, our current approaches to predict a patient’s recovery are anchored in clinical and phenotypical data and perform poorly. Surgical injury produces a multi-cellular immune response that, when dysregulated, leads to adverse surgical outcomes. Examining the human immune system in depth, in patients undergoing surgery is a logical and promising strategy to identify biological signatures for risk prediction and to reveal mechanisms that can be exploited to improve surgical recovery. Our research program utilizes the high-dimensional immune monitoring of patients undergoing surgery to identify modifiable immunological mechanisms that accurately predict a patient’s recovery. This MIRA proposal builds on our extensive translational research indicating that immune responses contained in the human Monocyte System (hMS) strongly correlate with pain resolution and functional recovery after major joint replacement surgery. We will pursue three inter-related, but non-overlapping goals focusing on the hMS: First, we will assess the phenotypic and functional dynamics of circulating monocytes in response to surgery to determine the role of the hMS in the pathobiology of surgical recovery. Second, we will interrogate the hMS before surgery to determine whether patients’ pre-surgical immune states determine the course of surgical recovery. Third, we will use a reverse translational strategy using a pre-clinical mouse model of surgery to test whether “druggable” immunological targets identified in humans can accelerate recovery. We will use the following innovative and multidisciplinary strategies: 1) high-dimensional profiling of the hMS in response to surgery using single-cell mass cytometry (including dynamic alterations in cell phenotype, homing properties and effector responses); 2) identification of cellular, epigenetic and proteomic elements of a patient’s hMS, using an integrative analytical pipeline developed by our group; 3) evaluation of new targets for selective modulation of monocyte signaling responses in a mouse model that recapitulates hallmarks of the human immune response to surgery. A major strength of this proposal is the study of trauma-related immunology in a pertinent patient population by a clinician-scientist who has effectively pioneered high-content immune monitoring techniques at the bedside. The current program focuses on pain and functional impairment after orthopedic surgery. However, we will study fundamental mechanisms that are likely shared across many acute inflammatory conditions (e.g. other surgeries, blunt trauma or traumatic brain injuries). As such, we will be able to pivot towards the integration of our findings within the broader immunologic, metabolic, and neuro-hormonal responses to injury and the evaluation of other adverse outcomes after traumatic injury, such as infections, sepsis, or neuro-cognitive impairment.
利用人体单核细胞系统提高手术恢复

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
High-multiplex tissue imaging in routine pathology-are we there yet?
  • DOI:
    10.1007/s00428-023-03509-6
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Einhaus, Jakob;Rochwarger, Alexander;Mattern, Sven;Gaudilliere, Brice;Schuerch, Christian M.
  • 通讯作者:
    Schuerch, Christian M.
Neuroimaging is the new "spatial omic": multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke.
  • DOI:
    10.1007/s00281-023-00984-6
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Maier, Benjamin;Tsai, Amy S.;Einhaus, Jakob F.;Desilles, Jean-Philippe;Ho-Tin-Noe, Benoit;Gory, Benjamin;Sirota, Marina;Leigh, Richard;Lemmens, Robin;Albers, Gregory;Olivot, Jean-Marc;Mazighi, Mikael;Gaudilliere, Brice
  • 通讯作者:
    Gaudilliere, Brice
Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset.
  • DOI:
    10.1126/scitranslmed.abd9898
  • 发表时间:
    2021-05-05
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Stelzer IA;Ghaemi MS;Han X;Ando K;Hédou JJ;Feyaerts D;Peterson LS;Rumer KK;Tsai ES;Ganio EA;Gaudillière DK;Tsai AS;Choisy B;Gaigne LP;Verdonk F;Jacobsen D;Gavasso S;Traber GM;Ellenberger M;Stanley N;Becker M;Culos A;Fallahzadeh R;Wong RJ;Darmstadt GL;Druzin ML;Winn VD;Gibbs RS;Ling XB;Sylvester K;Carvalho B;Snyder MP;Shaw GM;Stevenson DK;Contrepois K;Angst MS;Aghaeepour N;Gaudillière B
  • 通讯作者:
    Gaudillière B
Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease.
  • DOI:
    10.1093/ofid/ofab483
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Ward RA;Aghaeepour N;Bhattacharyya RP;Clish CB;Gaudillière B;Hacohen N;Mansour MK;Mudd PA;Pasupneti S;Presti RM;Rhee EP;Sen P;Spec A;Tam JM;Villani AC;Woolley AE;Hsu JL;Vyas JM
  • 通讯作者:
    Vyas JM
Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.
  • DOI:
    10.1016/j.chom.2021.10.009
  • 发表时间:
    2021-12-08
  • 期刊:
  • 影响因子:
    30.3
  • 作者:
    McIlwain DR;Chen H;Rahil Z;Bidoki NH;Jiang S;Bjornson Z;Kolhatkar NS;Martinez CJ;Gaudillière B;Hedou J;Mukherjee N;Schürch CM;Trejo A;Affrime M;Bock B;Kim K;Liebowitz D;Aghaeepour N;Tucker SN;Nolan GP
  • 通讯作者:
    Nolan GP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brice Gaudilliere其他文献

Brice Gaudilliere的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brice Gaudilliere', 18)}}的其他基金

Harnessing the human monocyte system to improve surgical recovery
利用人类单核细胞系统改善手术康复
  • 批准号:
    10227160
  • 财政年份:
    2020
  • 资助金额:
    $ 40.09万
  • 项目类别:
Harnessing the human monocyte system to improve surgical recovery
利用人类单核细胞系统改善手术康复
  • 批准号:
    10449343
  • 财政年份:
    2020
  • 资助金额:
    $ 40.09万
  • 项目类别:
Harnessing the human monocyte system to improve surgical recovery
利用人类单核细胞系统改善手术康复
  • 批准号:
    10027267
  • 财政年份:
    2020
  • 资助金额:
    $ 40.09万
  • 项目类别:
Role of Myeloid Derived Suppressor Cells in the Immune Response to Surgery
骨髓源性抑制细胞在手术免疫反应中的作用
  • 批准号:
    8911350
  • 财政年份:
    2014
  • 资助金额:
    $ 40.09万
  • 项目类别:
Role of Myeloid Derived Suppressor Cells in the Immune Response to Surgery
骨髓源性抑制细胞在手术免疫反应中的作用
  • 批准号:
    8753053
  • 财政年份:
    2014
  • 资助金额:
    $ 40.09万
  • 项目类别:
Role of Myeloid Derived Suppressor Cells in the Immune Response to Surgery
骨髓源性抑制细胞在手术免疫反应中的作用
  • 批准号:
    9127989
  • 财政年份:
    2014
  • 资助金额:
    $ 40.09万
  • 项目类别:

相似海外基金

Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes
确定肠易激综合症 (IBS) 的发病率、危险因素和生物驱动因素作为 SARS-CoV-2 感染急性后遗症 (PASC) 结果的一部分
  • 批准号:
    10630409
  • 财政年份:
    2023
  • 资助金额:
    $ 40.09万
  • 项目类别:
Elucidating the biological role of LonP1 in Acute Myeloid Leukemia and its potential as a therapeutic target for this disease
阐明 LonP1 在急性髓系白血病中的生物学作用及其作为该疾病治疗靶点的潜力
  • 批准号:
    485886
  • 财政年份:
    2022
  • 资助金额:
    $ 40.09万
  • 项目类别:
    Studentship Programs
Identification and Validation of Biological Sub-phenotypes of Sepsis-induced Acute Kidney Injury: A Precision Medicine Approach to Improve Clinical Outcomes
脓毒症引起的急性肾损伤的生物亚表型的鉴定和验证:改善临床结果的精准医学方法
  • 批准号:
    10674050
  • 财政年份:
    2022
  • 资助金额:
    $ 40.09万
  • 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10490338
  • 财政年份:
    2021
  • 资助金额:
    $ 40.09万
  • 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10353104
  • 财政年份:
    2021
  • 资助金额:
    $ 40.09万
  • 项目类别:
A multilaboratory study to investigate biological sex differences in a preclinical acute lung injury model
一项研究临床前急性肺损伤模型中生物性别差异的多实验室研究
  • 批准号:
    480624
  • 财政年份:
    2021
  • 资助金额:
    $ 40.09万
  • 项目类别:
    Studentship Programs
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10688286
  • 财政年份:
    2021
  • 资助金额:
    $ 40.09万
  • 项目类别:
Advancing acute kidney injury phenotyping using biological and clinical criteria
使用生物学和临床标准推进急性肾损伤表型分析
  • 批准号:
    9926251
  • 财政年份:
    2017
  • 资助金额:
    $ 40.09万
  • 项目类别:
Advancing acute kidney injury phenotyping using biological and clinical criteria
使用生物学和临床标准推进急性肾损伤表型分析
  • 批准号:
    10163159
  • 财政年份:
    2017
  • 资助金额:
    $ 40.09万
  • 项目类别:
Development of practical nursing support drills for chemical, biological, radiological, nuclear and explosive disaster in the acute phase to the mid-long term
开展化学、生物、放射性、核爆灾害急性期至中长期实用护理支持演练
  • 批准号:
    26670916
  • 财政年份:
    2014
  • 资助金额:
    $ 40.09万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了